FrancophonIA/ELRC3.0 huggingface dataset:
English: Luxembourg/Luxemburg S.A. Servier Benelux N.V. Tel: +32 (0)2 529 43 11
Slovenian: Luxembourg/Luxemburg S.A. Servier Benelux N.V.
English: o Current or previous venous thromboembolic events (VTE), including deep vein thrombosis and pulmonary embolism.
Slovenian: o s prisotno ali predhodno vensko trombembolijo (VTE), vključno z globoko vensko trombozo in pljučnim embolizmom, o ki so začasno ali stalno nepokretni zaradi npr. pooperativnega okrevanja ali podaljšanega mirovanja v postelji,
English: Table 2: Incidence of patients with hip fracture and relative risk reduction in patients with BMD ≤ -2.4 SD (NHANES III) and age ≥ 74 years
Slovenian: Preglednica 2: Pojavnost zlomov kolka in zmanjšanje relativnega tveganja pri bolnicah z mineralno kostno gostoto ≤
English: Moreover, the intended uses do not require medical supervision.
Slovenian: Prav tako predvidena uporaba ne zahteva zdravniškega nadzora.
English: This means that, although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in these ways for at least 30 years (including at least 15 years within the EU).
Slovenian: To pomeni, da je kljub nezadostnim dokazom iz kliničnih preskušanj učinkovitost teh zdravil rastlinskega izvora verjetna in da obstajajo dokazi o njihovi varni uporabi na navedene načine za vsaj 30 let (najmanj 15 let tudi v EU).
English: Melissa leaf should only be used in adults and children over the age of 12 years.
Slovenian: List melise se lahko uporablja samo pri odraslih in otrocih, starejših od 12 let.
English: Although a possible improvement in symptoms was observed, shortcomings in the design of the study prevented any firm conclusions being drawn.
Slovenian: Čeprav so zabeležili možno izboljšanje simptomov, zaradi pomanjkljivosti v zasnovi študije ni bilo mogoče izpeljati nobenih trdnih zaključkov.
English: Melissa leaf EMA/HMPC/310761/2013
Slovenian: List melise EMA/HMPC/310761/2013
English: This may be used to prepare extracts or tinctures (an alcoholic extract of the plant material).
Slovenian: Uporabljajo se lahko za pripravo izvlečkov ali tinktur (alkoholnega izvlečka rastlinskega materiala).
English: A doctor should be consulted if the symptoms persist following 2 weeks of treatment.
Slovenian: Če so simptomi po 2 tednih zdravljenja še vedno prisotni, se je treba posvetovati z zdravnikom.
English: This summary is not intended to provide practical advice on how to use medicines containing melissa leaf.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo list melise.
English: Melissa leaf is the common name for the leaf of the plant Melissa officinalis L. The plant is cultivated or gathered to obtain the leaf for medicinal use.
Slovenian: List melise je splošno ime za list rastline Melissa officinalis L. Rastlino se goji ali nabira, da se pridobijo listi za medicinsko uporabo.
English: The HMPC also considered published clinical studies, including a small study that examined the effects of melissa leaf preparations on symptoms of mild to moderate anxiety and sleep disturbance.
Slovenian: Odbor HMPC je prav tako preučil objavljene klinične študije, vključno z manjšo študijo, v kateri so preučevali učinke pripravkov lista melise pri simptomih blage do zmerne tesnobe in motnjah spanca.
English: Further information on the risks associated with melissa leaf medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih z zdravili, ki vsebujejo list melise, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of melissa leaf.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo lista melise.
English: Melissa leaf preparations are obtained by drying and powdering or comminuting (reducing into tiny pieces) the leaf.
Slovenian: Pripravki lista melise se pridobijo s sušenjem in z upraševanjem ali drobljenjem (zmanjšanjem na zelo majhne dele).
English: In its assessment, the HMPC took into account the well documented use of Melissa leaf for these indications.
Slovenian: Odbor HMPC je pri oceni upošteval dobro dokumentirano uporabo lista melise pri teh indikacijah.
English: The HMPC conclusions on the use of melissa leaf medicines for mild symptoms of stress, sleep aid and mild digestive disorders are based on their ‘traditional use' in these conditions.
Slovenian: Zaključki odbora HMPC o uporabi zdravil, ki vsebujejo list melise, za lajšanje blagih simptomov stresa, kot pomoč za uspavanje in lajšanje blagih prebavnih motenj temeljijo na njihovi „tradicionalni uporabi“ pri teh stanjih.
English: What is melissa leaf?
Slovenian: Kaj je list melise?
English: Melissa leaf can also be found in combination with other herbal substances in some herbal medicines.
Slovenian: List melise je v nekaterih zdravilih rastlinskega izvora lahko na voljo tudi v kombinaciji z drugimi rastlinskimi snovmi.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing melissa leaf.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo list melise.
English: The HMPC concluded that, on the basis of its long-standing use, melissa leaf can be used for the relief of mild symptoms of stress and to aid sleep.
Slovenian: Odbor HMPC je na osnovi dolgoletne uporabe lista melise zaključil, da se ga lahko uporablja za lajšanje blagih simptomov stresa in kot pomoč za uspavanje.
English: Further information on the HMPC assessment of melissa leaf medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo list melise, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: EMA/HMPC/310761/2013
Slovenian: EMA/HMPC/310761/2013 Odbor za zdravila rastlinskega izvora (HMPC)
English: Detailed instructions on how to take melissa leaf medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o jemanju zdravil, ki vsebujejo list melise, in o tem, kdo jih lahko jemlje, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: Information on the use and licensing of melissa leaf medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in dovoljenjih za promet z zdravili, ki vsebujejo list melise, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: How are melissa leaf medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo list melise, odobrena v EU?
English: Any applications for the licensing of medicines containing melissa leaf have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo list melise, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: It can also be used to treat the symptoms of mild digestive disorders including bloating and flatulence (wind).
Slovenian: Uporablja se lahko tudi za zdravljenje simptomov blagih prebavnih motenj, vključno z napenjanjem in flatulenco (nabiranje plinov v želodcu in črevesju, plini).
English: Melissa leaf
Slovenian: List melise
English: Herbal medicines containing melissa leaf are usually available as a herbal tea to be drunk, and in solid and liquid forms to be taken by mouth.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo list melise, so navadno na voljo kot zdravilni čaj za pitje ter v trdnih ali tekočih oblikah, ki se jemljejo peroralno (zaužijejo skozi usta).
English: Other information about melissa leaf medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo list melise
English: For more information about treatment with melissa leaf medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo list melise, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: Therefore, the HMPC conclusions on the use of melissa leaf medicines are based on their long-standing use.
Slovenian: Zaključki odbora HMPC v zvezi z uporabo zdravil, ki vsebujejo list melise, zato temeljijo na njihovi dolgotrajni uporabi.
English: What evidence supports the use of melissa leaf medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo list melise?
English: What are the risks associated with melissa leaf medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo list melise?
English: For practical information about using melissa leaf medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: (cannot be estimated from the available data)
Slovenian: (ni mogoče oceniti iz razpoložljivih podatkov)
English: Date of first authorisation: 28 May 2015
Slovenian: Datum prve odobritve: 28. maj 2015.
English: This is because it may seriously harm your baby.
Slovenian: To bi namreč lahko resno škodovalo vašemu otroku.
English: Urgent intervention is indicated.
Slovenian: Indicirana je urgentna intervencija.
English: The results of subgroup analyses should be interpreted with caution.
Slovenian: Rezultate analize podskupin je treba razlagati previdno.
English: • Take the capsules at about the same time each day.
Slovenian: • Kapsule vzemite vsak dan približno ob istem času.
English: Then take the next dose at the normal time.
Slovenian: Nato vzemite naslednji odmerek ob normalnem času.
English: Effects in humans are unknown.
Slovenian: Učinki pri ljudeh niso znani.
English: Frequencies are defined as:
Slovenian: Pogostnosti so opredeljene kot:
English: Urine protein should be monitored regularly.
Slovenian: Beljakovine v urinu je treba redno spremljati.
English: Includes cases with a fatal outcome.
Slovenian: Vključuje primere s smrtnim izidom.
English: Results are based on confirmed and unconfirmed responses.
Slovenian: c Rezultati temeljijo na potrjenih in nepotrjenih odzivih.
English: + = censored observations.
Slovenian: + = cenzurirani podatki.
English: • Median age: 62 years
Slovenian: • mediana starost: 62 let,
English: • are over 75 years
Slovenian: • ste starejši od 75 let;
English: • Male: 84%
Slovenian: • moški: 84 %,
English: The following terms have been combined: a:
Slovenian: Naslednji izrazi so bili združeni: a:
English: CI, confidence interval; NE, not estimable.
Slovenian: IZ, interval zaupanja; NE, ni mogoče oceniti.
English: Paediatric patients have not been studied.
Slovenian: Pediatričnih bolnikov niso proučevali.
English: The mechanism of action for hypothyroidism is not fully elucidated.
Slovenian: Mehanizem delovanja za hipotiroidizem ni popolnoma pojasnjen.
English: These findings were reversible at the end of a 4-week recovery period.
Slovenian: Te ugotovitve so bile reverzibilne ob koncu 4-tedenskega obdobja okrevanja.
English: • You can take the capsules with or without food.
Slovenian: • Kapsule lahko jemljete s hrano ali brez nje.
English: The effects of LENVIMA in people younger than 18 years old are not known.
Slovenian: Učinki zdravila LENVIMA pri ljudeh, mlajših od 18 let, niso znani.
English: Your doctor will help you decide whether the treatment should be continued.
Slovenian: Zdravnik vam bo pomagal pri odločitvi, ali naj se zdravljenje nadaljuje.
English: Independent radiologic review.
Slovenian: Neodvisen radiološki pregled.
English: Food does not affect the extent of absorption, but slows the rate of absorption.
Slovenian: Hrana ne vpliva na obseg absorpcije, a upočasni hitrost absorpcije.
English: The capsules should be taken at about the same time each day, with or without food (see section 5.2).
Slovenian: Kapsule je treba jemati vsak dan približno ob istem času, bodisi s hrano bodisi brez nje (glejte poglavje 5.2).
English: • belong to an ethnic group other than White or Asian
Slovenian: • pripadate etnični skupini, ki ni niti bela niti azijska;
English: ORRc, f, g (mRECIST)
Slovenian: ORRc, f, g (mRECIST) NA
English: • painful infection or irritation near the anus
Slovenian: • boleča okužba ali razdraženost blizu anusa,
English: Absolute bioavailability has not been determined in humans; however, data from a mass-balance study suggest that it is in the order of 85%.
Slovenian: Absolutne biološke uporabnosti pri ljudeh niso določili, vendar podatki iz študije masnega ravnovesja kažejo, da je približno 85 %.
English: Treatment should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.
Slovenian: Zdravljenje naj se nadaljuje, dokler je vidna klinična korist ali dokler se ne pojavi nesprejemljiva toksičnost.
English: • Do not use this medicine after the expiry date which is stated on the carton and on each blister after ‘EXP'.
Slovenian: • Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in na vsakem pretisnem omotu poleg oznake »EXP«.
English: If the submission of a PSUR and the update of an RMP coincide, they can be submitted at the same time.
Slovenian: Če predložitev PSUR in posodobitev RMP sovpadata, se lahko predložita sočasno.
English: Secondary efficacy outcome measures included overall response rate and overall survival.
Slovenian: Sekundarna merila izida učinkovitosti so vključevala celotno odzivnost in celotno preživetje.
English: What to do if you forget to take your dose depends on how long it is until your next dose.
Slovenian: Kaj storiti, če pozabite vzeti odmerek, je odvisno od tega, koliko še manjka do naslednjega odmerka.
English: • weigh less than 60 kg
Slovenian: • tehtate manj od 60 kg
English: If you forget to take LENVIMA Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
Slovenian: Če ste pozabili vzeti zdravilo LENVIMA Ne vzemite dvojnega odmerka (dveh odmerkov hkrati), da bi nadomestili pozabljeni odmerek.
English: Lenvatinib was not genotoxic.
Slovenian: Lenvatinib ni bil genotoksičen.
English: The adverse reaction frequency category represents the most conservative estimate of frequency from the two individual populations.
Slovenian: Kategorija pogostnosti neželenih učinkov je najbolj konzervativna ocena pogostnosti v dveh posameznih populacijah.
English: Juvenile animal toxicity studies
Slovenian: Študije toksičnosti na mladih živalih
English: Tell your doctor straight away if you notice any of the following side effects - you may need urgent medical treatment:
Slovenian: Nemudoma povejte zdravniku, če opazite katerega od naslednjih neželenih učinkov - mogoče boste potrebovali nujno medicinsko zdravljenje:
English: Eight healthy, demographically matched subjects served as controls and received a 10-mg dose.
Slovenian: Osem zdravih, demografsko podobnih preiskovancev je služilo za kontrole in prejelo 10-miligramski odmerek.
English: ANNEX II A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Slovenian: PRILOGA II A. PROIZVAJALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM D. POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA
English: Data cut-off date = 13 Nov 2016.
Slovenian: Presečni datum zajema podatkov = 13. november 2016.
English: How long to take LENVIMA You will usually carry on taking this medicine as long as you are getting benefit.
Slovenian: Kako dolgo jemljite zdravilo LENVIMA Navadno boste jemali to zdravilo tako dolgo, kolikor vam bo koristilo.
English: Age, sex, weight, race
Slovenian: Starost, spol, telesna masa, rasa
English: Symptoms depend on where the fistula is located.
Slovenian: Simptomi so odvisni od lokacije fistule.
English: • Body weight: <60 kg -31%, 60-80 kg - 50%, >80 kg - 19%
Slovenian: • telesna masa: < 60 kg - 31 %, 60-80 kg - 50 %, > 80 kg - 19 %,
English: Contraception, pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Slovenian: Kontracepcija, nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.
English: Estimated with Cox proportional hazard model.
Slovenian: Ocenjeno s Coxovim modelom proporcionalnih tveganj.
English: Lenvatinib is a substrate for P-gp and BCRP.
Slovenian: Lenvatinib je substrat za P-gp in BCRP.
English: Clinical data are not available in this population (see section 4.2).
Slovenian: Za to populacijo klinični podatki niso na voljo (glejte poglavje 4.2).
English: This is because the medicine passes into breast milk and may seriously harm your breastfed baby.
Slovenian: Zdravilo namreč prehaja v materino mleko in bi lahko resno škodovalo vašemu dojenemu otroku.
English: • you are allergic to lenvatinib or any of the other ingredients of this medicine (listed in section 6).
Slovenian: • če ste alergični na lenvatinib ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Baseline demographics and disease characteristics were well balanced for both treatment groups.
Slovenian: Izhodiščni demografski podatki in značilnosti bolezni so bili za obe zdravljeni skupini dobro uravnoteženi.
English: The median time to first dose reduction was 2.8 months.
Slovenian: Mediani čas do prvega zmanjšanja odmerka je bil 2,8 meseca.
English: • decrease in the number of white blood cells
Slovenian: • zmanjšanje števila belih krvnih celic,
English: • White: 29%, Asian: 69%, Black or African American: 1.4%
Slovenian: • bela rasa: 29 %, azijska: 69 %, črna ali afroameriška: 1,4 %,
English: A treatment decision should be made based upon an assessment of the individual patient's benefit/risk.
Slovenian: Odločitev o zdravljenju je treba sprejeti na podlagi ocene razmerja med koristmi in tveganji pri posameznem bolniku.
English: Therefore, mortality may be attributed to complications related to primary duodenal lesions with possible contribution from additional toxicities in immature target organs.
Slovenian: Zato lahko smrtnost pripišemo zapletom, povezanim s primarnimi duodenalnimi lezijami, z možnim prispevkom dodatnih toksičnosti v nezrelih ciljnih organih.
English: • loss of body fluids (dehydration)
Slovenian: • izguba telesnih tekočin (dehidracija),
English: Dose proportionality and accumulation
Slovenian: Proporcionalnost odmerku in akumulacija
English: • The recommended dose of LENVIMA depends on your body weight when you first start treatment.
Slovenian: • Priporočeni odmerek zdravila LENVIMA je odvisen od vaše telesne mase, ko prvič začnete zdravljenje.
English: Patients who experience these symptoms should use caution when driving or operating machines.
Slovenian: Bolniki, ki opazijo te simptome, naj bodo pri vožnji in upravljanju s stroji previdni.
English: System Organ Class (MedDRA terminology*)
Slovenian: Organski sistem (terminologija MedDRA*)
English: • headache and back pain
Slovenian: • glavobol in bolečina v hrbtu,
English: See section 4.8 Description of selected adverse reactions for further characterisation.
Slovenian: Glejte poglavje 4.8 Opis izbranih neželenih učinkov za nadaljnjo karakterizacijo.
English: Within each frequency category, undesirable effects are presented in order of decreasing seriousness.
Slovenian: V razvrstitvah pogostnosti so neželeni učinki navedeni po padajoči resnosti.
English: This leaflet was last revised in 09/2019
Slovenian: Navodilo je bilo nazadnje revidirano septembra 2019.
English: • have high blood pressure
Slovenian: • imate visok krvni tlak;
English: Concomitant administration of lenvatinib, carboplatin, and paclitaxel has no significant impact on the pharmacokinetics of any of these 3 substances.
Slovenian: Sočasna uporaba lenvatiniba, karboplatina in paklitaksela ni značilno vplivala na farmakokinetiko katere koli od teh treh snovi.
English: Lung metastases may also increase the risk of pneumothorax.
Slovenian: Pljučne metastaze lahko prav tako zvečujejo tveganje pnevmotoraksa.
English: Lenvatinib should not be used in children younger than 2 years of age because of safety concerns identified in animal studies (see section 5.3).
Slovenian: Lenvatinib se ne sme uporabljati pri otrocih, mlajših od 2 let, zaradi pomislekov glede varnosti, ugotovljenih v študijah na živalih (glejte poglavje 5.3).
English: The median cumulative RAI activity administered prior to study entry was 350 mCi (12.95 GBq).
Slovenian: Mediana kumulativna aktivnost RAI, dana pred vključitvijo v študijo, je bila 350 mCi (12,95 GBq).
English: The capsules should be swallowed whole with water.
Slovenian: Kapsule je treba pogoltniti cele z nekaj vode.
English: There are no data on the use of lenvatinib immediately following sorafenib or other anticancer treatments and there may be a potential risk for additive toxicities unless there is an adequate washout period between treatments.
Slovenian: Ni podatkov o uporabi lenvatiniba takoj po sorafenibu ali drugih zdravilih proti raku in lahko obstaja možno tveganje aditivnih toksičnosti, če med terapijami ni ustreznega obdobja spiranja.
English: Each carton contains 30 ,60,or 90 hard capsules.
Slovenian: Ena kartonska škatla vsebuje 30, 60 ali 90 trdih kapsul.
English: Life-threatening toxicities (Grade 4): Discontinuee a.
Slovenian: Življenjsko nevarne toksičnosti (stopnje 4): ukinitee a.
English: Median (95% CI) e Lenvatinib (N= 478)
Slovenian: Mediana (95-odstotni IZ) e lenvatinib (N= 478)
English: What LENVIMA is and what it is used for
Slovenian: Kaj je zdravilo LENVIMA in za kaj ga uporabljamo
English: Life-threatening consequences (malignant hypertension, neurological deficit, or hypertensive crisis)
Slovenian: življenjsko nevarne posledice (maligna hipertenzija, nevrološki deficit ali hipertenzivna kriza)
English: • high or low blood pressure
Slovenian: • visok ali nizek krvni tlak,
English: The safety and efficacy of lenvatinib in children aged 2 to <18 years have not yet been established (see section 5.1).
Slovenian: Varnost in učinkovitost lenvatiniba pri otrocih, starih od 2 do < 18 let, še nista bili dokazani (glejte poglavje 5.1).
English: • Barcelona Clinic Liver Cancer (BCLC) stage B: 20%; BCLC stage C: 80%
Slovenian: • stadij raka BCLC (Barcelona Clinic Liver Cancer) B: 20 %; stadij BCLC C: 80 %,
English: These in vivo metabolic routes align with the data provided in the in vitro studies using human biomaterials.
Slovenian: Te presnovne poti in vivo se ujemajo s podatki, ki so jih dale študije in vitro s človeškimi biomateriali.